Advertisement
Advertisement

CNS Pharmaceuticals sees cash runway into 2H26

As of June 30, 2025, the Company had cash of approximately $12.1 million. The Company believes that the cash on hand as of June 30, 2025 is sufficient to fund planned operations into the second half of 2026.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1